Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors

Journal of Bacteriology

Volumn 194, Issue 22, 2012, Pages 6195-6205

  Hadjifrangiskou, Maria ^a,c   Gu, Alice P ^b   Pinkner, Jerome S ^a,b   Kostakioti, Maria ^a   Zhang, Ellisa W ^a   Greene, Sarah E ^a   Hultgren, Scott J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM PILUS; BIOFILM; BLADDER EPITHELIUM; CONTROLLED STUDY; FLAGELLUM; GENE LIBRARY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROBIAL COMMUNITY; MOUSE; MUTAGENESIS; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPOSON; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; YEAST;

ANIMALS; BACTERIAL ADHESION; BIOFILMS; CLUSTER ANALYSIS; CYSTITIS; DNA TRANSPOSABLE ELEMENTS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; MICE; MICE, INBRED C3H; MUTAGENESIS; UROPATHOGENIC ESCHERICHIA COLI;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LURIA; MURINAE;

EID: 84869137864     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.01012-12     Document Type: Article

References (73)

1. Aberg A, Shingler V, Balsalobre C. 2008. Regulation of the fimB promoter: a case of differential regulation by ppGpp and DksA in vivo. Mol. Microbiol. 67:1223-1241.
2. Abraham JM, Freitag CS, Clements JR, Eisenstein BI. 1985. An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 82:5724-5727.
3. Anderson GG, Goller CC, Justice S, Hultgren SJ, Seed PC. 2010. Polysaccharide capsule and sialic acid-mediated regulation promote biofilm- like intracellular bacterial communities during cystitis. Infect. Immun. 78:963-975.
4. Anderson GG, Martin SM, Hultgren SJ. 2004. Host subversion by formation of intracellular bacterial communities in the urinary tract. Microbes Infect. 6:1094-1101.
5. Anderson GG, et al. 2003. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105-107.
6. Anriany Y, Sahu SN, Wessels KR, McCann LM, Joseph SW. 2006. Alteration of the rugose phenotype in waaG and ddhC mutants of Salmonella enterica serovar Typhimurium DT104 is associated with inverse production of curli and cellulose. Appl. Environ. Microbiol. 72:5002-5012.
7. Barnhart MM, Chapman MR. 2006. Curli biogenesis and function. Annu. Rev. Microbiol. 60:131-147.
8. Beloin C, et al. 2006. The transcriptional antiterminator RfaH represses biofilm formation in Escherichia coli. J. Bacteriol. 188:1316-1331.
9. Bian Z, Brauner A, Li Y, Normark S. 2000. Expression of and cytokine activation by Escherichia coli curli fibers in human sepsis. J. Infect. Dis. 181:602-612.
10. Bishop BL, et al. 2007. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat. Med. 13:625-630.
11. Blango MG, Mulvey MA. 2010. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob. Agents Chemother. 54:1855-1863.
12. Bouckaert J, et al. 2005. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. Mol. Microbiol. 55:441-455.
13. Bryan A, et al. 2006. Regulation of type 1 fimbriae by unlinked FimB- and FimE-like recombinases in uropathogenic Escherichia coli strain CFT073. Infect. Immun. 74:1072-1083.
14. Buckles EL, et al. 2004. Identification and characterization of a novel uropathogenic Escherichia coli-associated fimbrial gene cluster. Infect. Immun. 72:3890-3901.
15. Cegelski L, Pinkner JS, et al. 2009. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat. Chem. Biol. 5:913-919.
16. Chen SL, et al. 2006. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc. Natl. Acad. Sci. U. S. A. 103:5977-5982.
17. Cormack BP, Valdivia RH, Falkow S. 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33-38.
18. Dodson KW, et al. 2001. Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human kidney receptor. Cell 105:733-743.
19. Domka J, Lee J, Bansal T, Wood TK. 2007. Temporal gene expression in Escherichia coli K-12 biofilms. Environ. Microbiol. 9:332-346.
20. Eto DS, Jones TA, Sundsbak JL, Mulvey MA. 2007. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog. 3:e100. doi:10.1371/journal.ppat.0030100.
21. Ferrieres L, Hancock V, Klemm P. 2007. Biofilm exclusion of uropathogenic bacteria by selected asymptomatic bacteriuria Escherichia coli strains. Microbiology 153:1711-1719.
22. Garofalo CK, et al. 2007. Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infect. Immun. 75:52-60.
23. Goryshin IY, Jendrisak J, Hoffman LM, Meis R, Reznikoff WS. 2000. Insertional transposon mutagenesis by electroporation of released Tn5 transposition complexes. Nat. Biotechnol. 18:97-100.
24. Griebling TL. 2007. Urinary tract infection in women, p 589-617. In Litwin MS, Saigal CS (ed), Urologic diseases in America. NIH publication 07-5512. National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, MD.
25. Hadjifrangiskou M, et al. 2011. A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol. Microbiol. 80:1516-1529.
26. Hannan TJ, et al. 2008. LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis. Mol. Microbiol. 67:116-128.
27. Hasman H, Chakraborty T, Klemm P. 1999. Antigen-43-mediated autoaggregation of Escherichia coli is blocked by fimbriation. J. Bacteriol. 181:4834-4841.
28. Henderson JP, et al. 2009. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog. 5:e1000305. doi:10.1371/journal.ppat.1000305.
29. Hultgren SJ, Schwan WR, Schaeffer AJ, Duncan JL. 1986. Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli. Infect. Immun. 54:613-620.
30. Hung CS, et al. 2002. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol. Microbiol. 44:903-915.
31. Justice SS, et al. 2004. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. U. S. A. 101:1333-1338.
32. Kai-Larsen Y, et al. 2010. Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog. 6:e1001010. doi:10.1371/journal. ppat.1001010.
33. Kau AL, Hunstad DA, Hultgren SJ. 2005. Interaction of uropathogenic Escherichia coli with host uroepithelium. Curr. Opin. Microbiol. 8:54-59.
34. Klemm P. 1986. Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. EMBO J. 5:1389-1393.
35. Kline KA, Dodson KW, Caparon MG, Hultgren SJ. 2010. A tale of two pili: assembly and function of pili in bacteria. Trends Microbiol. 18:224-232.
36. Korhonen TK, et al. 1984. Escherichia coli fimbriae recognizing sialyl galactosides. J. Bacteriol. 159:762-766.
37. Kostakioti M, Hadjifrangiskou M, Pinkner JS, Hultgren SJ. 2009. QseCmediated dephosphorylation of QseB is required for expression of genes associated with virulence in uropathogenic Escherichia coli. Mol. Microbiol. 73:1020-1031.
38. Landini P, Zehnder AJ. 2002. The global regulatory hns gene negatively affects adhesion to solid surfaces by anaerobically grown Escherichia coli by modulating expression of flagellar genes and lipopolysaccharide production. J. Bacteriol. 184:1522-1529.
39. Lane MC, Alteri CJ, Smith SN, Mobley HL. 2007. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc. Natl. Acad. Sci. U. S. A. 104:16669-16674.
40. Lane MC, Simms AN, Mobley HL. 2007. Complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli. J. Bacteriol. 189:5523-5533.
41. Lenz AP, Williamson KS, Pitts B, Stewart PS, Franklin MJ. 2008. Localized gene expression in Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 74:4463-4471.
42. Lewis K. 2005. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc.) 70:267-274.
43. Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ. 2000. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J. 19:2803-2812.
44. Monds RD, O'Toole GA. 2009. The developmental model of microbial biofilms: ten years of a paradigm up for review. Trends Microbiol. 17: 73-87
45. Morschhauser J, Vetter V, Korhonen T, Uhlin BE, Hacker J. 1993. Regulation and binding properties of S fimbriae cloned from E. coli strains causing urinary tract infection and meningitis. Zentralbl. Bakteriol. 278: 165-176.
46. Mulvey MA, et al. 1998. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282:1494-1497.
47. Mulvey MA, Schilling JD, Hultgren SJ. 2001. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 69:4572-4579.
48. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ. 2000. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc. Natl. Acad. Sci. U. S. A. 97:8829-8835.
49. Murphy KC, Campellone KG. 2003. Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli. BMC Mol. Biol. 4:11. doi:10.1186/1471-2199-4-11.
50. Mysorekar IU, Hultgren SJ. 2006. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc. Natl. Acad. Sci. U. S. A. 103:14170-14175.
51. O'Toole G, Kaplan HB, Kolter R. 2000. Biofilm formation as microbial development. Annu. Rev. Microbiol. 54:49-79.
52. O'Toole GA, et al. 1999. Genetic approaches to study of biofilms. Methods Enzymol. 310:91-109.
53. Parsek MR, Singh PK. 2003. Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol. 57:677-701.
54. Pinkner JS, et al. 2006. Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc. Natl. Acad. Sci. U. S. A. 103:17897-17902.
55. Pratt LA, Kolter R. 1998. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol. Microbiol. 30:285-293.
56. Prigent-Combaret C, et al. 2001. Complex regulatory network controls initial adhesion and biofilm formation in Escherichia coli via regulation of the csgD gene. J. Bacteriol. 183:7213-7223.
57. Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ. 2007. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 4:e329. doi:10.1371/journal.pmed.0040329.
58. Schembri MA, Dalsgaard D, Klemm P. 2004. Capsule shields the function of short bacterial adhesins. J. Bacteriol. 186:1249-1257.
59. Schwan WR. 2008. Flagella allow uropathogenic Escherichia coli ascension into murine kidneys. Int. J. Med. Microbiol. 298:441-447.
60. Schwartz DJ, Chen SL, Hultgren SJ, Seed PC. 2011. Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection. Infect. Immun. 79:4250-4259.
61. Song J, et al. 2009. TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 106:14966-14971.
62. Thankavel K, et al. 1997. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. J. Clin. Invest. 100:1123-1136.
63. Thumbikat P, et al. 2009. Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog. 5:e1000415. doi:10.1371/ journal.ppat.1000415.
64. Uhlin BE, Norgren M, Baga M, Normark S. 1985. Adhesion to human cells by Escherichia coli lacking the major subunit of a digalactosidespecific pilus-adhesin. Proc. Natl. Acad. Sci. U. S. A. 82:1800-1804.
65. Ulett GC, Webb RI, Schembri MA. 2006. Antigen-43-mediated autoaggregation impairs motility in Escherichia coli. Microbiology 152:2101-2110.
66. Vuong C, et al. 2004. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell. Microbiol. 6:269-275.
67. Waksman G, Hultgren SJ. 2009. Structural biology of the chaperoneusher pathway of pilus biogenesis. Nat. Rev. Microbiol. 7:765-774.
68. Warren JW. 2001. Catheter-associated urinary tract infections. Int. J. Antimicrob. Agents 17:299-303.
69. Wiles TJ, Kulesus RR, Mulvey MA. 2008. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp. Mol. Pathol. 85:11-19.
70. Wright KJ, Seed PC, Hultgren SJ. 2007. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell. Microbiol. 9:2230-2241.
71. Wright KJ, Seed PC, Hultgren SJ. 2005. Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect. Immun. 73:7657-7668.
72. Xie B, et al. 2006. Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia. J. Biol. Chem. 281:14644-14653.
73. Zhou G, et al. 2001. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J. Cell Sci. 114:4095-4103.